Moteur de recherche d’entreprises européennes

Financement de l’UE (8 290 694 €) : PharmaLedger (en anglais seulement) Hor01/01/2020 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

PharmaLedger (en anglais seulement)

The PharmaLedger project will create a blockchain-based framework for the efficient digitization of the healthcare industry. The goal of the project is to provide a widely trusted platform that will support the design and adoption of blockchain-enabled healthcare solutions while accelerating delivery of innovation that will benefit the entire ecosystem, from manufacturers to patients. PharmaLedger will serve as a single source of truth for the healthcare ecosystem and will be designed for efficient decentralized governance, wide adoption by the stakeholders of the ecosystem, compliance with extant and emerging standards and regulation, and end-to-end connectivity and interoperability. Sustainability of the platform will be ensured by leveraging existing, successful blockchain technologies; open source reference implementation; and a fully documented, actionable methodology for evolutionary digitization of the healthcare industry. The project will address the key challenges of the healthcare ecosystem through prioritized delivery of applications and validation of business use cases, including but not be limited to end-to-end product tracking for combating counterfeit medicines and medical supplies; supply chain integrity; efficiency of recruitment and submission in clinical trials; and machine-learning health data marketplaces. The platform will support integrated use of medical devices across the use cases. The PharmaLedger project brings together 28 partners from 10 EU Member States, including 11 large pharmaceutical companies; highly innovative technology SMEs specializing in blockchain development, security, privacy and business intelligence; universities and research institutes specializing in pharmacoeconomic analysis, research of patient requirements, big data analytics and electronic health records; leading clinical trials companies; supply chain partners; patient representatives; and leading healthcare service providers.


ABBVIE Inc. 0,00 €
ARTEEVO TECHNOLOGIES Ltd. 906 250 €
Astrazeneca AB 0,00 €
BAYER AG 0,00 €
BOEHRINGER INGELHEIM INTERNATIONALGESELLSCHAFT mbH 0,00 €
Dimokritio Panepistimio Thrakis 216 250 €
EKON MODELING SOFWARE SYSTEMS Ltd.*EKON 456 250 €
Ethniko Kentro Erevnas Kai Technologikis Anaptyxis 282 500 €
European Forum for Good Clinical Practice 103 750 €
F. HOFFMANN-LA ROCHE AG 0,00 €
Forum des Patients Europeens 143 750 €
Glaxosmithkline Research & Development Ltd. 0,00 €
Imprensa Nacional - Casa da Moeda SA 365 625 €
Janssen Pharmaceutica N.V. 0,00 €
Katholieke Universiteit Leuven 338 500 €
MERCK SHARP & DOHME Corp. 0,00 €
National Research And Development Institute For Cryogenics And Isotopic Technologies Icsi RM Valcea 370 000 €
NOVARTIS PHARMA AG 0,00 €
Novo Nordisk A/S 0,00 €
Onorach Ltd. 511 569 €
Ospedale Pediatrico Bambino Gesu 347 500 €
PDM e FC-Projecto Desenvolvimento Manutencao Formacao e Consultadoria SA 823 125 €
Pfizer Ltd. 0,00 €
PHARMALEDGER Association 1,00 €
Romsoft Srl 1 157 500 €
Technovative Solutions Ltd. 910 625 €
UCB Biopharma 0,00 €
Unidade Local de Saude do Alentejo Central ΕΠΕ 176 250 €
Universidad Politecnica de Madrid 873 749 €
UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT 307 500 €

https://cordis.europa.eu/project/id/853992

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.